Haben Sie sich noch nicht registriert? Hier kostenlos Ihr Konto eröffnen.
Passwort vergessen? Wir werden Ihnen einen Zurücksetzen Link senden
11 November 2019
ORYX Confirms ParvOryx Mode of Action in Tumor Explant Model
4 November 2019
ORYX Provides Strategic Update on the Clinical Development of Oncolytic Virotherapy ParvOryx
30 Oktober 2019
ORYX Announces Positive Phase I/IIa Data for Oncolytic Virus ParvOryx Demonstrating Safety, Anti-tumor Effects, Partial Responses and Prolonged Overall Survival in Metastatic, Inoperable Pancreatic Cancer
16 Mai 2018
ORYX to Present Positive Clinical Data for Oncolytic Virus ParvOryx in Combination with Immune Modulators at CIMT Annual Meeting 2018
6 November 2017
ORYX: Positive data from Phase I/IIa clinical trial in glioblastoma with oncolytic virus ParvOryx published in peer-reviewed journal, Molecular Therapy
6 September 2017
ORYX to present positive clinical data with oncolytic virus ParvOryx in combination with immune activators at the Third CRI-CIMT-EATI-AACR Conference
23 Mai 2017
ORYX reports positive clinical evidence with oncolytic virus ParvOryx in combination with immuno-oncology drugs
4 April 2016
ORYX Enrols First Patients in a Dose-Escalating Phase I/IIa Pilot Study with Oncolytic Virus ParvOryx to Treat Metastatic Pancreatic Cancer
15 September 2015
ORYX Enrols First Patients in an Additional Phase I Trial with Therapeutic Vaccine VicOryx to Treat HPV-Associated Cancers in Combination with Standard Chemotherapy
12 Juni 2015
ORYX’ Oncolytic Virus ParvOryx Successfully Completes Phase I/IIa Trial to Treat Glioblastoma Multiforme
2 Juni 2015
ORYX Presents Positive Phase I/IIa Data with Therapeutic Vaccine MicOryx to Treat MSI-H Colorectal Cancers at ASCO 2015
18 Mai 2015
ORYX to Present Clinical Data for Therapeutic Vaccine MicOryx in Microsatellite Instable (MSI-H-) Colorectal Cancers at ASCO 2015
9 März 2015
ORYX Successfully Completes Phase I/IIa Trial with Therapeutic Vaccine VicOryx to Treat HPV-Associated Cancers
4 März 2015
ORYX’ Therapeutic Vaccine MicOryx Successfully Completes Phase I/IIa Trial to Treat MSH-H Colorectal Cancer
3 März 2015
ORYX to Present at Sachs European Life Science CEO Forum and Exhibition